Three Distinct Groups
In the summer of 2024, Wearables broadened our patient populations into three distinct groupings.
- Cardiothoracic Surgery: aims to predict and prevent postoperative complications and monitor recovery & motivation in patients undergoing major cardiothoracic surgery.
- Surgical Expansion: aims to predict and prevent postoperative complications and monitor recovery & motivation in patients undergoing general, colorectal, pancreatic, vascular, orthopedic, and/or orthopedic surgery alongside chemotherapy.
- Systemic Therapy: aims to monitor physiologic response and recovery to IV chemotherapy and/or immunotherapy (chemo/IO) for a diagnosis of cancer.